KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

AbbVie (ABBV) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for AbbVie (ABBV) over the last 14 years, with Q3 2025 value amounting to 12.07%.

  • AbbVie's EBITDA Margin fell 144200.0% to 12.07% in Q3 2025 from the same period last year, while for Sep 2025 it was 15.16%, marking a year-over-year decrease of 97300.0%. This contributed to the annual value of 16.22% for FY2024, which is 72700.0% down from last year.
  • AbbVie's EBITDA Margin amounted to 12.07% in Q3 2025, which was down 144200.0% from 31.73% recorded in Q2 2025.
  • In the past 5 years, AbbVie's EBITDA Margin registered a high of 36.39% during Q4 2022, and its lowest value of 9.87% during Q4 2024.
  • Its 5-year average for EBITDA Margin is 25.53%, with a median of 27.98% in 2025.
  • In the last 5 years, AbbVie's EBITDA Margin surged by 246000bps in 2021 and then crashed by -322100bps in 2024.
  • Over the past 5 years, AbbVie's EBITDA Margin (Quarter) stood at 34.09% in 2021, then grew by 7bps to 36.39% in 2022, then crashed by -39bps to 22.34% in 2023, then crashed by -144bps to 9.87% in 2024, then skyrocketed by 222bps to 12.07% in 2025.
  • Its EBITDA Margin was 12.07% in Q3 2025, compared to 31.73% in Q2 2025 and 27.98% in Q1 2025.